Anzeige
Mehr »
Login
Dienstag, 27.02.2024 Börsentäglich über 12.000 News von 684 internationalen Medien
Nurexone Biologic: Prof. Levenberg erklärt, wie die ExoTherapy funktioniert!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A11664 | ISIN: US03209R1032 | Ticker-Symbol: 29A
Tradegate
26.02.24
21:22 Uhr
51,50 Euro
+0,50
+0,98 %
1-Jahres-Chart
AMPHASTAR PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
AMPHASTAR PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
50,5051,0009:07
50,5051,0008:27

Aktuelle News zur AMPHASTAR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiAmphastar (AMPH) to Report Q4 Earnings: What's in the Cards?1
20.02.Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2024311RANCHO CUCAMONGA, CA / ACCESSWIRE / February 20, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its fourth quarter of 2023 ended December 31...
► Artikel lesen
16.02.It May Be Time To Revisit Amphastar Once It Settles After A Plunge3
02.01.Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference470RANCHO CUCAMONGA, CA / ACCESSWIRE / January 2, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Dr. Jack Zhang, CEO and President, and Bill Peters, CFO will be presenting at...
► Artikel lesen
20.11.23Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference353RANCHO CUCAMONGA, CA / ACCESSWIRE / November 20, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Dan Dischner, S.V.P. of Corporate Communications, will...
► Artikel lesen
17.11.23BofA starts Amphastar at neutral; cites high valuation, Baqsimi prospects9
15.11.23Amphastar Pharmaceuticals director discloses sale of 5K shares3
10.11.23Amphastar Pharmaceuticals Stock Earns Composite Rating Upgrade6
09.11.23Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference429RANCHO CUCAMONGA, CA / ACCESSWIRE / November 9, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Jacob Liawatidewi EVP of Corp. Administration, will participate...
► Artikel lesen
09.11.23Amphastar Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary6
08.11.23Amphastar Pharmaceuticals, Inc. - 10-Q, Quarterly Report3
08.11.23Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2023335Reports Net Revenues of $180.6 Million for the Three Months Ended September 30, 2023RANCHO CUCAMONGA, CA / ACCESSWIRE / November 8, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar"...
► Artikel lesen
07.11.23Earnings Preview For Amphastar Pharma4
01.11.23Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2023305RANCHO CUCAMONGA, CA / ACCESSWIRE / November 1, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its third quarter of 2023 ended September 30...
► Artikel lesen
15.09.23Amphastar Pharmaceuticals, Inc. - 8-K, Current Report5
13.09.23Amphastar Pharmaceuticals prices $300M senior notes7
13.09.23Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals Announces Pricing of Offering of $300.0 Million of Convertible Senior Notes414RANCHO CUCAMONGA, CA / ACCESSWIRE / September 13, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar") today announced the pricing of $300.0 million aggregate principal amount of 2.00%...
► Artikel lesen
11.09.23Amphastar Pharmaceuticals announces proposed private offering of $300M of convertible senior notes11
11.09.23Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals Announces Proposed Private Offering of $300.0 Million of Convertible Senior Notes485RANCHO CUCAMONGA, CA / ACCESSWIRE / September 11, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar") today announced that it intends to offer, subject to market conditions and other...
► Artikel lesen
31.08.23Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the Wells Fargo Healthcare Conference501RANCHO CUCAMONGA, CA / ACCESSWIRE / August 31, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, EVP of Regulatory Affairs and Clinical Operations...
► Artikel lesen
Seite:  Weiter >>
31 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2